| 0 Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the first quarter ending March 31, 2021. “Building on our momentum from last year, Hims & Hers kicked off 2021 with a very strong first quarter, delivering robust revenue growth of 74%, gross profit growth of 95%, and ending the quarter with 391,000 subscriptions on our platform, up nearly 80% year-over-year, said Andrew Dudum, CEO and co-founder of Hims & Hers. “We made significant headway on our mission of making the highest quality, personalized healthcare accessible to everyone, and we continued to set ourselves apart in the industry with our unified and fully verticalized front door to care.”
By Kendra Clark-06 April 2021 11:00am
A dose of their own medicine: a new wave of brands are bundling healthcare and DTC pharmaceutical sales.
Telehealth has quickly become a regular part of our lives. Now, a new generation of pharma brands are using this channel to upend the sales and marketing status quo within this highly regulated industry.
Pharmaceutical advertising featuring cheery images of people frolicking, picnicking and (according to the voiceover talent) living their best lives has become tired to the point of memeification.
What’s emerging in its place is a new school of brands ditching the traditional approach in favor of a radically new business model that combines telehealth, direct-to-consumer (DTC) sales and deft marketing.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Hims & Hers Appoints Two New Board Members
March 10, 2021 GMT
SAN FRANCISCO (BUSINESS WIRE) Mar 10, 2021
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced the appointment of Andrea Perez and Ambar Bhattacharyya to the company’s Board of Directors. Following the company’s recent entry onto the NYSE, Perez and Bhattacharyya join Hims & Hers at a pivotal moment not only for the brand, but at an inflection point in the healthcare industry as the COVID-19 pandemic has accelerated the need for equitable access to healthcare and highlighted the value of telemedicine.